Robert E.Hoffman

CFO at Cytodyn Inc.

Presenter

Robert E. Hoffman is the Chief Financial Officer of CytoDyn Inc., bringing decades of financial leadership to the biotechnology sector. Appointed in May 2025, he oversees the company's capital allocation, strategic budgeting, and fundraising efforts to advance its clinical trials.Mr. Hoffman’s extensive executive track record includes serving as President and CEO of Kintara Therapeutics, and as CFO for Heron Therapeutics, AnaptysBio, and Arena Pharmaceuticals. A recognized financial expert, he also serves on the boards of FibroBiologics, TuHURA Biosciences, and Esperion Therapeutics. Mr. Hoffman previously advised the Financial Accounting Standards Board.